DEANA SAP: Open Payments
NPI 1235844838 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 24 payments from 10 companies in 2025. Trend: 2023 $448 · 2024 $376 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 8 | $139 |
| Amgen Inc. | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 2 | $79 |
| SCPHARMACEUTICALS INC. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
Products named: Fabhalta, KRYSTEXXA, FUROSCIX, Kerendia, JYNARQUE, Dojolvi, ULTOMIRIS, TAVNEOS.
Industry payments across SC — which companies pay providers there.
